These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 826748)

  • 21. Interaction of sulfur-containing analogs of ATP with adenylate cyclase.
    Bär HP; Simonson LP; Eckstein F
    FEBS Lett; 1974 May; 41(2):199-202. PubMed ID: 4859367
    [No Abstract]   [Full Text] [Related]  

  • 22. Receptors for ATP in rat sensory neurones: the structure-function relationship for ligands.
    Krishtal OA; Marchenko SM; Obukhov AG; Volkova TM
    Br J Pharmacol; 1988 Dec; 95(4):1057-62. PubMed ID: 3219481
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition by amiloride of both adenylate cyclase activity and the Na+/H+ antiporter in fish erythrocytes.
    Mahé Y; Garcia-Romeu F; Motais R
    Eur J Pharmacol; 1985 Oct; 116(3):199-206. PubMed ID: 3000798
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of adenylate cyclase by adenosine and other agonists in rat myocardial sarcolemma.
    Anand-Srivastava MB
    Arch Biochem Biophys; 1985 Dec; 243(2):439-46. PubMed ID: 2417561
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Control of histone modification within chromatin by adenine nucleotides and steroid hormones.
    Burdon RH; Pearce CA
    Biochem J; 1971 Jul; 123(4):37P. PubMed ID: 4331321
    [No Abstract]   [Full Text] [Related]  

  • 26. Membrane changes during cartilage maturation. Increase in 5'-nucleotidase and decrease in adenosine inhibition of adenylate cyclase.
    Rodan GA; Bourret LA; Cutler LS
    J Cell Biol; 1977 Feb; 72(2):493-501. PubMed ID: 833206
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prostaglandin E2 Stimulates EP2, Adenylate Cyclase, Phospholipase C, and Intracellular Calcium Release to Mediate Cyclic Adenosine Monophosphate Production in Dental Pulp Cells.
    Chang MC; Lin SI; Lin LD; Chan CP; Lee MS; Wang TM; Jeng PY; Yeung SY; Jeng JH
    J Endod; 2016 Apr; 42(4):584-8. PubMed ID: 26906242
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of adenylate cyclase activity by polyamines in human erythrocyte plasma membranes.
    Khan NA; Quemener V; Moulinoux P
    Life Sci; 1990; 46(1):43-7. PubMed ID: 2105420
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Conditions associated with the appearance of guanine nucleotide-dependent adenylate cyclase activity in turkey erythrocyte membranes.
    Morris SA; Bilezikian JP
    Biochem Pharmacol; 1982 Sep; 31(17):2783-90. PubMed ID: 7138573
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of adenylate cyclase activity in liver and fat cell membranes by insulin.
    Illiano G; Cuatrecasas P
    Science; 1972 Feb; 175(4024):906-8. PubMed ID: 4332823
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of adenylate cyclase by transglutaminase-catalyzed reactions in pigeon erythrocyte ghosts.
    Porta R; De Santis A; Esposito C; Draetta GF; Di Donato A; Illiano G
    Biochem Biophys Res Commun; 1986 Jul; 138(2):596-603. PubMed ID: 2874804
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulation of vasopressin action by reducing agents in Bufo marinus.
    Butkus DE; Schwartz JH
    Am J Physiol; 1982 Jul; 243(1):C52-61. PubMed ID: 6283908
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of adenylate cyclase by adenosine analogues in preparations of broken and intact human platelets. Evidence for the unidirectional control of platelet function by cyclic AMP.
    Haslam RJ; Davidson MM; Desjardins JV
    Biochem J; 1978 Oct; 176(1):83-95. PubMed ID: 215136
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ca2+-induced inhibition of adenylyl cyclase in turkey erythrocyte membranes.
    Demirel E; Ugur O; Onaran HO
    Pharmacology; 1998 Oct; 57(4):222-8. PubMed ID: 9730780
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Age-dependent changes in the adenylate cyclase and phosphodiesterase activity of rat erythrocytes.
    Shappard H; Burghardt CR
    Biochem Pharmacol; 1973 Feb; 22(3):427-9. PubMed ID: 4347013
    [No Abstract]   [Full Text] [Related]  

  • 36. Pitfalls in the use of lead nitrate for the histochemical demonstration of adenylate cyclase activity.
    Lemay A; Jarett L
    J Cell Biol; 1975 Apr; 65(1):39-50. PubMed ID: 165205
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular basis for P-site inhibition of adenylyl cyclase.
    Tesmer JJ; Dessauer CW; Sunahara RK; Murray LD; Johnson RA; Gilman AG; Sprang SR
    Biochemistry; 2000 Nov; 39(47):14464-71. PubMed ID: 11087399
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characteristics of the guanine nucleotide regulatory component of adenylate cyclase in human erythrocyte membranes.
    Nielsen TB; Lad PM; Preston MS; Rodbell M
    Biochim Biophys Acta; 1980 Apr; 629(1):143-55. PubMed ID: 6245715
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence against adenylate cyclase-coupled adenosine receptors in the guinea pig heart.
    Schütz W; Tuisl E
    Eur J Pharmacol; 1981 Dec; 76(2-3):285-8. PubMed ID: 6277647
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of brain adenylate cyclase by A1 adenosine receptors: pharmacological characteristics and locations.
    Ebersolt C; Premont J; Prochiantz A; Perez M; Bockaert J
    Brain Res; 1983 May; 267(1):123-9. PubMed ID: 6305455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.